SOPHiA GENETICS (SOPH) Receivables (2020 - 2026)

SOPHiA GENETICS has disclosed Receivables across 7 years of filings, most recently posting $14.1 million for Q2 2026.

• In Q2 2026, Receivables rose 48.47% year-over-year to $14.1 million; the TTM figure through Jun 2026 stood at $14.1 million (up 48.47% YoY), while the FY2025 annual figure was $15.0 million, up 101.73% from the prior year.
• Receivables came in at $14.1 million for Q2 2026 at SOPHiA GENETICS, down from $14.3 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $15.0 million in Q4 2025 to a low of $6.3 million in Q1 2022.
• Average Receivables over 5 years is $10.0 million, with a median of $9.8 million recorded in 2023.
• Year-over-year, Receivables surged 103.9% in 2023 and sank 45.15% in 2024.
• Over 5 years, Receivables stood at $6.6 million in 2022, then surged by 103.9% to $13.6 million in 2023, then slumped by 45.15% to $7.4 million in 2024, then soared by 101.73% to $15.0 million in 2025, then declined by 5.93% to $14.1 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $14.1 million in Q2 2026, $14.3 million in Q1 2026, and $15.0 million in Q4 2025.